Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Central IDE Cervix Study Showing 98.6% of Spinal Fusions Occurring in Patients Treated with i-FACTOR®
WESTMINSTER, Colo., Oct. 17, 2023 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedic company committed to redefining the standard of care for bone repair, today announced long-term follow-up data from its pivotal IDE study of i-FACTOR Peptide-Enhanced Bone Graft. Published data demonstrated single-level anterior cervical discectomy and fusion (ACDF) fusion rates of 98.6% after six years…